IPS IPSOS

Ipsos: Monthly declaration of shares and voting rights - May 2024

Ipsos: Monthly declaration of shares and voting rights - May 2024

June 28, 2024

MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS

Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF

Date



 
Shares



 
Voting rights
Theoretical* Exercisable**
31 May 2024 43,203,225 48,809,240 48,773,315

*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights.

**For information purposes, this number excludes the shares which voting rights have been suspended.

The information is also available in the « Regulated Information » section of the Ipsos website: .

Attachment



EN
28/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IPSOS

 PRESS RELEASE

Ipsos: Half-year report on IPSOS’ liquidity contract - June 2025

Ipsos: Half-year report on IPSOS’ liquidity contract - June 2025                                                         July 21, 2025 Half-year report on IPSOS’ liquidity contract with Exane BNP PARIBAS Under the liquidity contract entrusted by IPSOS SA to Exane BNP Paribas, the following assets appeared on the liquidity account as at June 30, 2025: 26,173 IPSOS shares€399,116 During the 1st half 2025, it has been traded a total of: Purchase61,133 shares€2,677,607780 transactionsSale61,211 shares€2,709,695792 transactions For information, the following assets appeared on the liquidity ...

 PRESS RELEASE

Ipsos : Bilan semestriel du contrat de liquidité IPSOS - Juin 2025

Ipsos : Bilan semestriel du contrat de liquidité IPSOS - Juin 2025                                                        21 juillet 2025 Bilan semestriel du contrat de liquidité IPSOS contracté avec la société Exane BNP PARIBAS Au titre du contrat de liquidité confié par la société IPSOS SA à Exane BNP PARIBAS, en date de dénouement du 30 juin 2025, les moyens suivants figuraient au compte de liquidité : 26 173 titres IPSOS399 116 € Au cours du 1er semestre 2025, il a été négocié un total de : Achat61 133 titres2 677 607 €780 transactionsVente61 211 titres2 709 695 €792 transactions ...

 PRESS RELEASE

Ipsos strengthens its expertise in Germany with the acquisition of InM...

Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division Paris, 7 July 2025 - , one of the world's leading market research companies, announces the acquisition of InMoment’s Healthcare division in Germany, enabling to bolster its expertise in this sector and generate further growth opportunities in the country. Ben Page, CEO of Ipsos, stated: “We are pleased to welcome the experienced InMoment German Healthcare team to Ipsos, adding a new competence ce...

 PRESS RELEASE

Ipsos renforce son expertise en Allemagne avec l'acquisition de la div...

Ipsos renforce son expertise en Allemagne avec l'acquisition de la division Santé d'InMoment Ipsos renforce son expertise en Allemagne avec l'acquisition de la division Santé d'InMoment Paris, 7 juillet 2025 - , l’une des principales sociétés mondiales d’études de marché, annonce l'acquisition de la division Santé d'InMoment en Allemagne, lui permettant de renforcer son expertise dans ce secteur et de générer de nouvelles opportunités de croissance dans le pays. Ben Page, Directeur Général d’Ipsos, a déclaré : « Nous sommes heureux d'accueillir l'équipe allemande expérimentée d'InMoment ...

 PRESS RELEASE

Ipsos Strengthens Its Board of Directors

Ipsos Strengthens Its Board of Directors Ipsos Strengthens Its Board of Directors Paris, June 30, 2025 – Ipsos announces the appointment of three new members to its Board of Directors: Ms. Armelle Carminati-Rabasse, Mr. Lionel Chaine, and Ms. Anne-Marie Couderc. The appointments of Mr. Chaine, as the permanent representative of Bpifrance Investissement, and Ms. Carminati-Rabasse follow the votes held at the Company’s Annual General Meeting on May 21, 2025.The Board of Directors, meeting on June 20, 2025, decided to co-opt Ms. Anne-Marie Couderc to replace Ms. Florence Parly, who stepped d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch